Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Promising signs in UC research into treating ovarian cancer

Promising signs in UC research into treating ovarian cancer

October 17, 2012

A University of Canterbury (UC) research project in collaboration with the Christchurch School of Medicine has shown some promising signs in the treatment of ovarian cancer.

UC student researcher Simon Hogg said ovarian cancer was a challenging disease to treat and was classed as the most lethal gynaecological cancer.

Without effective methods for screening and early detection, patients are typically not diagnosed until the disease has spread beyond the ovary and can become resistant to anti-cancer drugs. There is a desperate need for a new anti-cancer drug to improve the survival of women with advanced disease, Hogg said today.

He said his research found that naturally-occurring compounds could be employed to fight ovarian cancer.

``We are beginning to realise the clinical potential of these compounds. My study adds to a growing body of knowledge identifying naturally-occurring compounds in our diet which help fight against cancer. This is an exciting opportunity because compared to many synthetic drugs, naturally-occurring compounds are cheap, non-toxic, and easily accessible to the general public.

``Ongoing research at UC in collaboration with Dr Kenny Chitcholtan from the Department of Obstetrics and Gynaecology at the Christchurch School of Medicine aims to shed further light on compounds present in food and beverages that may be useful for entirely natural therapeutic interventions.

``Data I collected is consistent with the idea that lifestyle factors are associated with the rates of certain cancers, notably through dietary exposure. The identification of these compounds present in food and beverages that play anti-tumour roles against cancer is important for completing our understanding of the disease itself and guiding the design of new therapeutics.’’

Hogg’s research, supervised by UC’s Dr Ashley Garrill, studied the anti-tumour effects in advanced ovarian cancer cells. Results from his study suggested further investigation was warranted.

``The compounds used in my research were all naturally-occurring compounds produced by plants. The problem was that the compound (resveratrol) was quickly eliminated from the body before it could exert a beneficial effect.

``My results are significant as they suggest acetyl-resveratrol has similar anti-tumour activity to the parental compound, resveratrol. I believe that natural-occurring compounds are a feasible source of chemicals that can be employed to fight cancer,’’ Hogg said.

He will deliver his findings at the UC’s annual science biology conference on campus today.
ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

What Winter? Temperature Records Set For June 20-22

The days around the winter soltice produced a number of notably warm tempertaures. More>>

Conservation Deal: New Kākāpō Recovery Partnership Welcomed

Conservation Minister Maggie Barry says the new kakapo recovery partnership between DOC and Meridian Energy is great news for efforts to save one of New Zealand’s most beloved birds. More>>

ALSO:

Tech Sector Report: Joyce Warns Asian Tech Investors View NZ As Hobbits And Food

Speaking in Wellington at the launch of a report showcasing the value of the technology sector to the New Zealand economy, Joyce said more had to be done to tell the country's technology stories overseas. More>>

ALSO:

Mediaglommeration: APN Gets OIO Approval For Demerger Plan

APN News & Media has received Overseas Investment Office approval for its plan to split out its NZME unit ahead of a potential merger with rival Fairfax Media's New Zealand operations. More>>

New Paper: Ninety-Day Trial Period Has No Impact On Firms' Hiring

The introduction of a 90-day trial period has had no impact on hiring by New Zealand companies although they are now in widespread use, according to researchers at Motu Economic and Public Policy Research. More>>

ALSO:

Corrections: Serco Exits Equity Stake, Remains As Operator

Serco has sold its equity stake in the company that holds the contract to design, build and run Wiri Prison in South Auckland but continues as sub-contractor to operate the facility. More>>

GDP: NZ Economy Grows Faster-Than-Forecast 0.7%

New Zealand's economy grew at a faster pace than expected in the first quarter of 2016 as construction expanded at the quickest rate in two years. The kiwi dollar jumped after the data was released. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news